A carregar...
Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the β-Lactamase Inhibitor Vaborbactam (RPX7009) in Healthy Adult Subjects
Vaborbactam (formerly RPX7009) is a member of a new class of β-lactamase inhibitor with pharmacokinetic properties similar to those of many β-lactams, including carbapenems. The pharmacokinetics and safety of vaborbactam were evaluated in 80 healthy adult subjects in a first-in-human randomized, pla...
Na minha lista:
Publicado no: | Antimicrob Agents Chemother |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society for Microbiology
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5038296/ https://ncbi.nlm.nih.gov/pubmed/27527080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00568-16 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|